MedPath

standard chemotherapy plus aspirin vs standard chemotherapy alone in locally advanced and metastatic stomach cancer

Phase 2
Conditions
Health Condition 1: null- advanced stomach cancer patients able to take tablets orally with normal organ function and a good performance statusHealth Condition 2: C169- Malignant neoplasm of stomach, unspecified
Registration Number
CTRI/2017/11/010651
Lead Sponsor
Jawaharlal Institute of Post graduate Medical education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Locally advanced and metastatic gastric cancer patients

2. Performance status
3. Able to take oral medications

4. normal platelet counts

Exclusion Criteria

1. Significant organ dysfunction such as a.cardiac EF <50%, b.Serum creatinine >2mg/dl, c. Altered liver function-serum bilirubin >1.5mg/dl, AST/ALT >3xULN, ALP >5xULN

2. previously on any dose of Aspirin

3. Aspirin hypersensitivity

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath